Guangzhou Yichen Cloud Health Technology recently has garnered tens of millions yuan in Series A round of financing, which was led by Redhill Capital, and followed by Yuchuang Capital and Tsingyuan Ventures I LP.
This round of financing will be mainly used for factory construction, clinical trials and product declarations.
Yichen Cloud Health, headquartered in Guangzhou, is committed to the prevention of nosocomial infections with innovative technologies.
The company has independently researched and developed technologies and a number of global patents, aiming to provide services to more patients. In addition, it has set up R&D center and subsidiary in Silicon Valley, USA.
The management staff of Yichen Cloud Health have years of working experience in the medical sector. The CEO Jiang Qiongcheng has designed and developed a number of disruptive innovative medical products and kept the company’s profits doubled for many years, who graduated from Sun Yat-sen University and Stanford University.
The CFO Tang Yina used to serve as a senior analyst at Morgan Stanley in the US, who graduated from John Hopkins University.
The COO Tang Erhu used to serve as an executive of Baxter and Edwards Lifescience, multinational companies of medical device, having more than 20 years of experience in the sector of medical device.